The Data Migration Project is coming to an end October 1, 2018, at which point HREBA-CC will process all ethics files through the IRISS system. Paper/e-mail submissions will no longer be accepted, and HREBA will not be able to help with the migration of any remaining paper files. For details see this memo.
For cancer studies reviewed by the HREBA Cancer Committee:
For studies reviewed by the HREBA Community Health Committee:
There are new HREBA Reportable Events Forms which must be used as of 01 February 2018:
HREBA Local Adverse Events Report Form (V2 01 Feb 2018)
HREBA Non-Local Adverse Events Report Form (V2 01 Feb 2018)
HREBA Additional Reportable Events Form (V2 01 Feb 2018)
There is also a new HREBA Protocol Deviation Form (V2 01 Feb 2018).
The 2018 meeting dates and submission deadlines are available for all HREBA Committees.
2018 Cancer Committee Dates and Deadlines
2018 Clinical Trials Committee Dates and Deadlines
2018 Community Health Committee Dates and Deadlines
Please note that there are no exceptions to the submission deadlines.
If your study is industry funded, please submit a HREBA Billing Information Form_Nov 2017.
A Reportable Events Module in IRISS is available for those who have studies reviewed by the Cancer or Clinical Trials Committees.
Guidance is available for those who need to know what events are significant enough to report.
The Health Research Ethics Board of Alberta (HREBA) charges $4000 for the initial full board review, or $1000 for the initial delegated review, of an industry funded study.
All industry funded studies, regardless of their initial approval date, will not be charged any additional fees for changes e.g. modifications, annual renewals, closures.
Under exceptional circumstances and to ensure a quality review for each study submitted, the Health Research Ethics Board of Alberta (HREBA) may at times limit the number of studies reviewed at a committee meeting.
As necessary, only 10 complete applications received prior to the submission deadline may be assigned to a meeting. If such a limitation is put in place, applicants of studies that are not being reviewed at that particular meeting will be notified.
Note that submissions are administratively screened upon receipt. Those requiring revisions are not assigned to a meeting until the requested changes have been made. For a pdf version please see the memo HREBA Submission Management Policy.
The Health Research Ethics Board of Alberta (HREBA) is recruiting members with expertise in research content and methodology, privacy and members of the community. These include:
The Role:
Successful nominees will join either the Clinical Trials Committee or the Cancer Committee to help ensure that the rights and welfare of research participants within the province of Alberta are adequately protected in accordance with the Tri-Council Policy Statement on the Ethical Conduct for Research Involving Humans (TCPS 2014) and other regulatory requirements.
Members attend a monthly meeting and receive an honorarium. Depending on the committee, meetings are held either in Edmonton or Edmonton and Calgary. These are three-year term positions (2017-2020) that are renewable for an additional term.
How to Apply:
Please send a letter of interest and Curriculum Vitae outlining relevant qualifications and if applicable a summary of your research and ethics experience to:
Wendy Burrill, Associate Director of Research Ethics
Alberta Innovates
Email: wendy.burrill@albertainnovates.ca
Nominations will be accepted until the positions are filled.
Background Information:
The Health Research Ethics Board of Alberta is managed by Alberta Innovates. HREBA’s three committees provide ethics reviews of research throughout the province that relies on health information under the authority of the Alberta Health Information Act. These committees include:
For all other inquiries regarding the HREBA, please contact info@hreba.ca.
The 2017 Committee meeting dates and deadlines are on each Committee’s page and are linked below.
Cancer Committee Clinical Trials Committee Community Health Committee
